NCT00480194
Completed
Not Applicable
A Non-interventional, Non-controlled, Post-marketing Study to Obtain Knowledge of the Safety of ZyComb® (Xylometazoline Hydrochloride 0.5 mg/mL and Ipratropium Bromide 0.6 mg/mL) for Symptoms of Common Cold in a Real-life OTC Setting
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Common Cold
- Sponsor
- Nycomed
- Enrollment
- 1000
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
The objectives of the study are to obtain knowledge about the safety in use, the patients' general impression of the treatment and the pattern of use of ZyComb® in an over-the-counter (OTC) setting.
Investigators
Eligibility Criteria
Inclusion Criteria
- •For inclusion the patient must buy ZyComb® nasal spray with the intention to start using it either the same or the next day.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
remedē System Therapy StudyCentral Sleep ApneaNCT03884660Respicardia, Inc.225
Completed
Not Applicable
Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic DrugEpilepsies, PartialNCT01098162UCB Pharma GmbH576
Completed
Not Applicable
Application of Ectoin Containing Lozenges (EHT02) in Patients With Acute, Viral Pharyngitis.Acute Viral PharyngitisNCT03943186Bitop AG102
Active, not recruiting
Not Applicable
A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible for TransplantMultiple MyelomaNCT03106324Celgene911
Completed
Not Applicable
Safety and Performance of a GLOBAL Mapping and Ablation Device for the Treatment of Atrial Fibrillation (GLOBAL-AF)Atrial FibrillationNCT02168972Kardium Inc.60